Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 85101-85150 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05233384
Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia
N/A
Active, not recruiting
70 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
7 locations
NCT05456893
A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies
N/A
Recruiting
95 participants
Started: Jul 28, 2022 · Completed: Sep 9, 2027
2 conditions
1 sponsor
1 location
NCT06870942
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
PHASE2
Recruiting
35 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05342519
Daily Topical Rapamycin for Vitiligo
PHASE2
Active, not recruiting
20 participants
Started: Jul 28, 2022 · Completed: Aug 1, 2026
1 condition
2 sponsors
1 location
NCT05307666
MinMed: Do Older Adults do Better With Less Medication
PHASE4
Enrolling by invitation
1,800 participants
Started: Jul 28, 2022 · Completed: Sep 30, 2025
3 conditions
1 sponsor
1 location
NCT05327608
Neoadjuvant Breast Cancer Time Restricted Eating
NA
Recruiting
55 participants
Started: Jul 28, 2022 · Completed: May 1, 2027
7 conditions
1 sponsor
1 location
NCT06094322
Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging
NA
Active, not recruiting
34 participants
Started: Jul 28, 2022 · Completed: Jun 9, 2025
1 condition
1 sponsor
1 location
NCT05481723
Lung Ultrasound-guided Hemodynamic Optimization
PHASE3
Recruiting
350 participants
Started: Jul 28, 2022 · Completed: Aug 31, 2027
3 conditions
1 sponsor
1 location
NCT05393622
Brain Stimulation for Severe Depression
NA
Recruiting
20 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05439629
Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration
PHASE3
Active, not recruiting
488 participants
Started: Jul 28, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
48 locations
NCT05458648
A Prospective Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm
N/A
Active, not recruiting
39 participants
Started: Jul 28, 2022 · Completed: Aug 30, 2024
2 conditions
2 sponsors
1 location
NCT05908682
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
N/A
Recruiting
100 participants
Started: Jul 28, 2022 · Completed: Oct 31, 2029
3 conditions
2 sponsors
1 location
NCT05350072
Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
PHASE3
Active, not recruiting
276 participants
Started: Jul 28, 2022 · Completed: May 6, 2027
1 condition
1 sponsor
78 locations
NCT05555693
Correlation Between Postoperative Cognitive-related Adverse Reactions and Brain Metabolomic Characteristics in Elderly Patients
N/A
Recruiting
200 participants
Started: Jul 27, 2022 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT05072314
Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
PHASE3
Recruiting
4,300 participants
Started: Jul 27, 2022 · Completed: Jul 31, 2028
4 conditions
2 sponsors
43 locations
NCT05353439
Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer
PHASE1
Recruiting
60 participants
Started: Jul 27, 2022 · Completed: Apr 1, 2027
6 conditions
1 sponsor
14 locations
NCT05400317
A Study to Evaluate the Efficacy and Safety of AD-218
PHASE3
Recruiting
520 participants
Started: Jul 27, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05168605
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
NA
Recruiting
100 participants
Started: Jul 27, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05200208
Improving Sleep and Cognition in Alzheimer's Disease
NA
Active, not recruiting
20 participants
Started: Jul 27, 2022 · Completed: Oct 31, 2025
1 condition
3 sponsors
2 locations
NCT05180773
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
PHASE4
Recruiting
250 participants
Started: Jul 27, 2022 · Completed: Dec 31, 2028
1 condition
2 sponsors
64 locations
NCT04765514
Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
PHASE2
Recruiting
121 participants
Started: Jul 27, 2022 · Completed: Jun 30, 2032
1 condition
1 sponsor
2 locations
NCT05273788
Thoracic Neuromodulation for Diabetic Gastroparesis
PHASE1
Recruiting
48 participants
Started: Jul 27, 2022 · Completed: May 31, 2026
1 condition
3 sponsors
1 location
NCT05342636
A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)
PHASE1/PHASE2
Active, not recruiting
120 participants
Started: Jul 27, 2022 · Completed: Nov 13, 2025
1 condition
1 sponsor
46 locations
NCT05244239
Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer
PHASE1
Recruiting
22 participants
Started: Jul 27, 2022 · Completed: Jul 28, 2025
2 conditions
3 sponsors
3 locations
NCT05442060
To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE2
Recruiting
60 participants
Started: Jul 27, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
7 locations
NCT05203835
Trial of Acebilustat for the Treatment of Upper Arm Lymphedema
PHASE2
Active, not recruiting
40 participants
Started: Jul 27, 2022 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT05367037
Physiological Ventricular Pacing Vs Managed Ventricular Pacing for Persistent AF Prevention in Prolonged AV Interval
NA
Recruiting
640 participants
Started: Jul 27, 2022 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT05434598
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
NA
Recruiting
60 participants
Started: Jul 27, 2022 · Completed: Aug 31, 2027
2 conditions
3 sponsors
1 location
NCT05297786
Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease
PHASE2
Active, not recruiting
28 participants
Started: Jul 27, 2022 · Completed: Aug 31, 2025
2 conditions
1 sponsor
1 location
NCT05322226
Addiction Intervention in Liver Transplantation Candidates
NA
Active, not recruiting
64 participants
Started: Jul 27, 2022 · Completed: Sep 26, 2025
2 conditions
1 sponsor
1 location
NCT04903080
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma
PHASE1
Active, not recruiting
50 participants
Started: Jul 27, 2022 · Completed: Jul 20, 2043
1 condition
5 sponsors
13 locations
NCT05129020
Neurostimulation to Improve NOWS Outcomes
NA
Active, not recruiting
52 participants
Started: Jul 27, 2022 · Completed: Aug 31, 2025
2 conditions
4 sponsors
3 locations
NCT04928508
Advanced or Recurrent Solid Tumors Treated With SHetA2
PHASE1
Recruiting
50 participants
Started: Jul 27, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT05488483
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
N/A
Active, not recruiting
12 participants
Started: Jul 27, 2022 · Completed: Jul 27, 2026
2 conditions
1 sponsor
4 locations
NCT06909877
Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma
PHASE1/PHASE2
Recruiting
100 participants
Started: Jul 27, 2022 · Completed: Jul 30, 2027
1 condition
1 sponsor
1 location
NCT05473507
A Study of Observation and Follow-up in People With Basal Cell Carcinoma
N/A
Active, not recruiting
26 participants
Started: Jul 27, 2022 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT05899049
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study
PHASE3
Active, not recruiting
249 participants
Started: Jul 27, 2022 · Completed: Dec 1, 2026
1 condition
2 sponsors
17 locations
NCT05053113
Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women
NA
Recruiting
500 participants
Started: Jul 27, 2022 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT04014179
Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs
NA
Active, not recruiting
2,700 participants
Started: Jul 27, 2022 · Completed: Jul 31, 2026
2 conditions
1 sponsor
17 locations
NCT05124925
Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.
PHASE2
Active, not recruiting
21 participants
Started: Jul 27, 2022 · Completed: Jun 16, 2026
1 condition
1 sponsor
1 location
NCT06075160
Resting Full-cycle Ratio (RFR)-Guided Revascularization
N/A
Recruiting
1,167 participants
Started: Jul 27, 2022 · Completed: Dec 31, 2026
1 condition
12 sponsors
1 location
NCT05407909
To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors
PHASE1
Recruiting
176 participants
Started: Jul 27, 2022 · Completed: Jan 6, 2026
1 condition
1 sponsor
1 location
NCT05422066
Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma
PHASE2
Recruiting
50 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
6 locations
NCT05404945
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
PHASE2
Recruiting
44 participants
Started: Jul 26, 2022 · Completed: Oct 3, 2027
1 condition
2 sponsors
3 locations
NCT05229614
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
PHASE2
Recruiting
27 participants
Started: Jul 26, 2022 · Completed: Aug 31, 2026
4 conditions
4 sponsors
4 locations
NCT05165511
Families, Responsibility, Education, Support, and Health for Executive Function
NA
Recruiting
30 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06588348
Corticosteroid Effect on Achalasia Variant EGJOO
EARLY_PHASE1
Active, not recruiting
12 participants
Started: Jul 26, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT06163365
Inherited Cancer Early Diagnosis (ICED) Study
N/A
Recruiting
100 participants
Started: Jul 26, 2022 · Completed: Jul 26, 2025
8 conditions
1 sponsor
1 location
NCT05472558
Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL
PHASE1
Recruiting
48 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04989504
Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy
PHASE3
Active, not recruiting
216 participants
Started: Jul 26, 2022 · Completed: Feb 15, 2029
2 conditions
2 sponsors
49 locations
Previous
1
More pages
1700
1701
1702
1703
1704
1705
1706
More pages
2369
Next